SEC Form 4 · accession 0001209191-17-032038
NovoCure Ltd · NVCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
W Anthony Vernon
Director
Period of report
May 10, 2017
Accepted (ET)
May 12, 2017 · 4:56 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001645113
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options to Buy Ordinary SharesF1 | $12.30 | May 10, 2017 | A | 23,600 | A | — | May 10, 2027 | Ordinary Shares | 23,600 | 23,600 | D |
Explanation of responses
- F1Options to buy 23,600 ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the date of the Company's 2018 annual general meeting of shareholders.